Novartis looking to add more medicines to direct to patient platform, CEO says

Core Insights - Swiss drugmaker Novartis is planning to enhance its direct-to-patient platform by adding more medicines, with the platform set to launch in the U.S. next month [1] Company Developments - CEO Vas Narasimhan indicated that the company is actively exploring options for expanding its medicine offerings on the new platform [1]